Gilad Almogy is the founder of Ultima Genomics. Ultima Genomics has raised $700M in total funding. Latest round: Series C. Based in Palo Alto, United States.
Gilad Almogy is the Founder and CEO of Ultima Genomics, a genomics company he founded in 2016 to develop affordable DNA sequencing technology aimed at delivering the $100 genome. He has led the company from stealth mode through major funding rounds, securing over $700 million in total backing from leading investors. Almogy is based in Palo Alto, California, where Ultima Genomics is headquartered.
Full founder directory · Investor directory · Company funding database · Fundraising library